Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors

Prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is of major interest in AD research. A large number of potential predictors have been proposed, with most investigations tending to examine one or a set of related predictors. In this study, we simultaneously examined multiple features from different modalities of data, including structural magnetic resonance imaging (MRI) morphometry, cerebrospinal fluid (CSF) biomarkers and neuropsychological and functional measures (NMs), to explore an optimal set of predictors of conversion from MCI to AD in an Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. After FreeSurfer-derived MRI feature extraction, CSF and NM feature collection, feature selection was employed to choose optimal subsets of features from each modality. Support vector machine (SVM) classifiers were then trained on normal control (NC) and AD participants. Testing was conducted on MCIc (MCI individuals who have converted to AD within 24 months) and MCInc (MCI individuals who have not converted to AD within 24 months) groups. Classification results demonstrated that NMs outperformed CSF and MRI features. The combination of selected NM, MRI and CSF features attained an accuracy of 67.13%, a sensitivity of 96.43%, a specificity of 48.28%, and an AUC (area under curve) of 0.796. Analysis of the predictive values of MCIc who converted at different follow-up evaluations showed that the predictive values were significantly different between individuals who converted within 12 months and after 12 months. This study establishes meaningful multivariate predictors composed of selected NM, MRI and CSF measures which may be useful and practical for clinical diagnosis.

[1]  W. M. van der Flier,et al.  CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. , 2009, JAMA.

[2]  J. Pariente,et al.  Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve , 2009, Brain : a journal of neurology.

[3]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[4]  S. Leurgans,et al.  MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD , 2004, Neurobiology of Aging.

[5]  R. Mayeux,et al.  Hippocampal and entorhinal atrophy in mild cognitive impairment , 2007, Neurology.

[6]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[7]  J. Trojanowski,et al.  Biomarkers for Early Detection of Alzheimer Pathology , 2007, Neurosignals.

[8]  B T Hyman,et al.  Temporoparietal MR Imaging Measures of Atrophy in Subjects with Mild Cognitive Impairment That Predict Subsequent Diagnosis of Alzheimer Disease , 2009, American Journal of Neuroradiology.

[9]  P. Scheltens,et al.  Advances in the early detection of Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[10]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[11]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[12]  A. Dale,et al.  Multi-modal imaging predicts memory performance in normal aging and cognitive decline , 2010, Neurobiology of Aging.

[13]  Ludovico Minati,et al.  Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review , 2009, American journal of Alzheimer's disease and other dementias.

[14]  R. Petersen,et al.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.

[15]  Masao Kishikawa,et al.  Early diagnosis of Alzheimer's? , 1994, Nature.

[16]  Anders M. Dale,et al.  Sequence-independent segmentation of magnetic resonance images , 2004, NeuroImage.

[17]  A. Dale,et al.  Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease , 2010, American Journal of Neuroradiology.

[18]  Clifford R. Jack,et al.  Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies , 2008, NeuroImage.

[19]  C. Jack,et al.  Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance , 2012, Neurobiology of Aging.

[20]  S. Resnick,et al.  Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging , 2008, Neurobiology of Aging.

[21]  P. Rubé,et al.  L’examen Clinique en Psychologie , 1959 .

[22]  Arthur W. Toga,et al.  Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment , 2011, NeuroImage.

[23]  R. Chapman,et al.  Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods , 2011, Journal of clinical and experimental neuropsychology.

[24]  Christos Davatzikos,et al.  Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI , 2009, NeuroImage.

[25]  Anders M. Dale,et al.  Regional Shape Abnormalities in Mild Cognitive Impairment and Alzheimer's Disease , 2009, NeuroImage.

[26]  J. C. BurgesChristopher A Tutorial on Support Vector Machines for Pattern Recognition , 1998 .

[27]  B. L. Beattie,et al.  The Clock Test: A Sensitive Measure To Differentiate Normal Elderly from Those with Alzheimer Disease , 1992, Journal of the American Geriatrics Society.

[28]  Chih-Jen Lin,et al.  A Practical Guide to Support Vector Classication , 2008 .

[29]  Carlo Caltagirone,et al.  Amnestic mild cognitive impairment: difference of memory profile in subjects who converted or did not convert to Alzheimer's disease. , 2007, Neuropsychology.

[30]  Chris H. Q. Ding,et al.  Minimum redundancy feature selection from microarray gene expression data , 2003, Computational Systems Bioinformatics. CSB2003. Proceedings of the 2003 IEEE Bioinformatics Conference. CSB2003.

[31]  A. Burns Clinical diagnosis of Alzheimer's disease , 1991 .

[32]  Nikos Makris,et al.  Automatically parcellating the human cerebral cortex. , 2004, Cerebral cortex.

[33]  R. Reitan Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[34]  Ana Madevska Bogdanova,et al.  Probabilistic SVM outputs for pattern recognition using analytical geometry , 2004, Neurocomputing.

[35]  Lars Bäckman,et al.  Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. , 2005, Neuropsychology.

[36]  Marie Chupin,et al.  Automatic classi fi cation of patients with Alzheimer ' s disease from structural MRI : A comparison of ten methods using the ADNI database , 2010 .

[37]  Nick C Fox,et al.  The clinical use of structural MRI in Alzheimer disease , 2010, Nature Reviews Neurology.

[38]  Daoqiang Zhang,et al.  Multimodal classification of Alzheimer's disease and mild cognitive impairment , 2011, NeuroImage.

[39]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[40]  Xiaoying Wu,et al.  Structural and functional biomarkers of prodromal Alzheimer's disease: A high-dimensional pattern classification study , 2008, NeuroImage.

[41]  et al.,et al.  Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline , 2008, NeuroImage.

[42]  A. Dale,et al.  Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. , 2009, Radiology.

[43]  Fuhui Long,et al.  Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy , 2003, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[44]  M. Weiner,et al.  Automated MRI measures predict progression to Alzheimer's disease , 2010, Neurobiology of Aging.

[45]  Li Shen,et al.  Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort , 2009, Current Alzheimer research.

[46]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[47]  K. Blennow,et al.  Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study , 2006, The Lancet Neurology.

[48]  Isabelle Guyon,et al.  An Introduction to Variable and Feature Selection , 2003, J. Mach. Learn. Res..

[49]  J. Trojanowski,et al.  Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification , 2011, Neurobiology of Aging.

[50]  Robert M. Chapman,et al.  Brain ERP components predict which individuals progress to Alzheimer's disease and which do not , 2011, Neurobiology of Aging.

[51]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[52]  Owen Carmichael,et al.  Update on the Magnetic Resonance Imaging core of the Alzheimer's Disease Neuroimaging Initiative , 2010, Alzheimer's & Dementia.

[53]  E. Kaplan,et al.  The Boston naming test , 2001 .

[54]  T. Kurosaki,et al.  Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.